Skip to content

Evaluating the Effectiveness of Chlamydia Trachomatis Genital Infection Testing and Treatment Strategy in Preventing Adverse Pregnancy Outcomes: a Randomized Controlled Trial Study

Evaluating the Effectiveness of Chlamydia Trachomatis Genital Infection Testing and Treatment Strategy in Preventing Adverse Pregnancy Outcomes: a Randomized Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000031549
Enrollment
Unknown
Registered
2020-04-04
Start date
2020-06-01
Completion date
Unknown
Last updated
2021-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Genital Chlamydia Trachomatis Infection

Interventions

Intervention Group:Urine samples will be immediately tested for chlamydia infection
Chlamydia infection-positive women will take a dose of 1g Azithromycin for the treatment.
Control Group:No intervention

Sponsors

Dermatology Hospital of Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 39 Years

Inclusion criteria

Inclusion criteria: 1. Pregnant women with 6 to 12 weeks in gestation; 2. aged 18 to 39 years old; 3. on their first antenatal visit; 4. plan to give birth in a hospital located in the present district; 5. agree to participate and sign a consent document.

Exclusion criteria

Exclusion criteria: 1. Pregnant women used antibiotics within one month before the first perinatal visit; 2. conceive through In vitro fertilization (IVF); 3. diagnosed with Ct. infection and received treatment in recent three months; 4. plan to have an abortion; 5. have a severe mental disease which may impede the follow-up; 6. refuse to sign a consent document.

Design outcomes

Primary

MeasureTime frame
Spontaneous Abortion;Preterm Labor;Premature Repture of Membranes;Stillbirth;Small for Gestational Age;Low Birth Weight;Endometritis;Chorioamnionitis;Birth Defects;Pre-eclampsia;Intrauterine Growth Restriction;Abruptio Placentae;

Secondary

MeasureTime frame
Neonatal Conjunctivitis;Neonatal Pneumonia;Direct Medical Cost;Indirect Medical Cost;Indirect Cost;Fixed Costs;Time Cost;

Countries

China

Contacts

Public ContactWeiming Tang

Dermatology Hospital of Southern Medical University, UNC Project-China

weiming_tang@med.unc.edu+86 15920567132

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 9, 2026